What Are We? Scientists Create the First Human-Monkey Chimera Embryos

In April 2021, an international team of researchers published a paper in Cell that did exactly this. They were trying to figure out how to grow human organs in animals — a practical problem, given that about 17 people die every day in the United States waiting for organ transplants. Their solution: take 132 cynomolgus macaque embryos, inject each with 25 human stem cells, and see what happened.

What happened, biologically, was remarkable. Human cells survived and integrated at rates far exceeding any previous human-primate attempt. At six days, 103 embryos were still alive. By day 19 — when the experiment ended per ethical protocols — three chimeric embryos remained viable.

What happened philosophically was a quiet detonation.

Because when you ask "can we grow human organs in a monkey," you first have to ask what makes an organ human. And when you ask what makes an organ human, you find yourself asking what makes you human. And when you follow that question all the way down, you discover that the boundary separating "human" from "not human" was a line you drew, not a wall that exists.

The chimera embryo is an invitation to stare into that void.

i · the experiment: what actually happened

The research was led by teams at the Salk Institute and Stanford University, working with scientists in China and Spain, with Juan Carlos Izpisua Belmonte as senior author. They injected 25 human extended pluripotent stem cells (hEPSCs) into each of 132 cynomolgus monkey embryos at day 1 of development — before the cells have committed to becoming any particular tissue.

Extended pluripotent stem cells are an important technical detail. Regular pluripotent stem cells can become most body tissues; these sit slightly earlier in the developmental hierarchy — they can also become extraembryonic tissues like placenta, giving them broader developmental range and potentially better integration into an early embryo's environment.

The researchers chose this approach specifically because prior chimera attempts had failed. Pig-human and sheep-human chimeras produced integration rates of roughly 1 in 100,000 to 1 in 1,000,000 cells — vanishingly small, enough to question whether genuine chimeras had been produced at all. The new approach aimed to put cells into a developmental context where the gap between donor and host was smaller.

It worked. Human cells were found throughout the surviving embryos: in cells that would have become gut, heart, kidney, and liver tissue. And in cells that would have become neural tissue.

The researchers used fluorescent markers to track human versus macaque cells at each stage of development. What they found wasn't simply parallel development — human and macaque cells appearing side by side in the same embryo. They found cells communicating across species lines, responding to each other's developmental signals, producing outcomes that neither genome anticipated running alone.

This is biologically unprecedented for human-primate chimeras. It is also, ethically, a category problem that existing frameworks were not designed to handle.

Previous experiments could gesture at the remoteness of true integration — pigs and humans are separated by roughly 90 million years of evolution, and the cells didn't mix well anyway. Macaque monkeys and humans share a much more recent common ancestor. Our developmental programs are more similar. Which is exactly why the cells survived better. And exactly why the ethical stakes climb.

The experiment ended at day 19, in compliance with international norms derived from the "14-day rule" governing human embryo research. The researchers were not growing human-monkey hybrid animals. They were growing human-monkey hybrid embryos, and the distinction between those two things is one of degree and time, not of kind.

ii · the question behind the question

Here's what the chimera embryo actually does to you: it makes the word "human" feel suddenly slippery.

You arrived at this article with a working sense of what "human" means. Homo sapiens. Bipedal, large-brained, language-using, self-aware. The species. The thing you are. The thing that is implicitly on one side of a meaningful line.

The chimera embryo blurs that line at the cellular level. If 25 human cells are injected into a macaque embryo and begin co-developing with primate cells — integrating into tissues that would have become a nervous system, responding to macaque developmental signals, forming hybrid regulatory environments — what are those cells? What is the cluster of cells that contains them? Where does the human start and the monkey end?

The obvious answer is: it's mostly monkey. Human cells were a minority at injection and remained a minority throughout. But "mostly monkey" is an answer that works by counting. And counting doesn't settle the question. It just translates it into arithmetic.

The question underneath is about identity. What makes something what it is?

Identity is pattern, not substance. You are not the atoms in your body — those get replaced continuously, and most of your cells turn over within years. You are a pattern of organization, a dynamic structure that persists through constant material change. The "you" reading this now shares almost no physical material with the "you" who was five years old, and yet something persists — some organizational continuity — that makes them the same entity.

The chimera embryo applies direct pressure to this frame. Human stem cells don't import "humanness" as a package. They bring human DNA and human developmental programming, which then interacts with a macaque developmental environment. What emerges is neither human programming running unimpeded nor macaque development proceeding normally. It's a negotiated pattern. A hybrid regulatory environment. Cells running human code in a primate context, producing outputs neither genome evolved to anticipate.

This is not metaphor. This is what the researchers observed under fluorescence microscopy.

The implications split into two directions, and both are real.

The optimistic direction is therapeutic. If human cells can reliably integrate into primate embryos and follow developmental signals toward specific tissues, the pathway toward growing functional human organs in animals becomes credible. The technology is years from clinical use and requires solving profound biological and ethical problems simultaneously — but it's a direction that points toward ending one of medicine's most persistent and lethal supply problems.

The less comfortable direction is consciousness. Neural tissue is the category that keeps bioethicists awake, because it's where identity lives — or where we've decided identity lives, which is not quite the same thing. The 2021 study found human cells in neural progenitor tissue. The experiment ended before any meaningful nervous system structure could form.

But "we stopped before it got interesting" is a deferral, not an answer. If this research continues — and it will, somewhere, by someone, because the organ transplant incentive is enormous — the question of what you do with a primate carrying partial human neural integration will become practical rather than hypothetical. Current regulatory frameworks have no settled answer. Animal welfare law doesn't contemplate it. Human rights frameworks definitely don't. There is no legal or ethical category for "entity that is 15% human at the level of its developing nervous system."

There needs to be one, before the experiment runs long enough to require it.

The field is aware of this. Japan relaxed its rules on chimera research in 2019, previously one of the stricter regulatory environments globally. The US National Institutes of Health lifted a moratorium on funding human-animal chimera research in 2016, with caveats — specifically excluding primate embryos from the relaxed rules until the science caught up. The 2021 result is that science catching up. Regulatory frameworks will have to move faster now, or the experiment will outrun them.

The ethics review cleared the 2021 study — the researchers had followed protocols, ended development early, and been transparent. But the reviewing bodies also noted that the frameworks governing this work were developed for a world where human-primate chimeras didn't exist. They were applying rules built on assumptions that the experiment had just empirically undermined.

This is how the void opens. Not with drama, but with a result that quietly dissolves a boundary you didn't know you were relying on.

The question "what are we?" has always been partly philosophical. Descartes, Kant, the whole tradition — people have been circling it for centuries without needing biology to weigh in. The chimera embryo makes it biological. And when biology refuses to draw a clean line, philosophy has to catch up.

The researchers were asking: can we grow human organs in a monkey?

The embryo answered with a question: what, exactly, do you mean by human?

The void doesn't answer that. It just waits while you figure out you've been assuming the answer all along.

iii · sources

• International team creates first chimeric human-monkey embryos — STAT News, 2021-04-15
• Chimeric contribution of human extended pluripotent stem cells to monkey embryos ex vivo — Cell, 2021-04-15
• Scientists create first human-monkey hybrid embryos in China — Science Daily, 2021-04-15
• Human-Monkey Chimeric Embryos Raise Ethical Concerns — The Scientist, 2021-04-15